PODD
Insulet Corporation NMS · PODD
$164.06
-0.37
(-0.23%)
Neutral · +0.91σ
Grade C
Price alert —
Loading…
Sign in to get a one-time email the moment PODD crosses your price. Free accounts included.
Sign in / create a free account
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire Inc.
·
8d ago
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Insulet Corporation (PODD)
GlobeNewswire Inc.
·
12d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth Inc. - GOCO
GlobeNewswire Inc.
·
88d ago
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment
The Motley Fool
·
125d ago
Insulet Stock Hits 52-Week Low - Here's Why
Benzinga
·
127d ago
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market
Benzinga
·
155d ago
BVI Appoints Jim Hollingshead as President & Chief Executive Officer
GlobeNewswire Inc.
·
180d ago
Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock
Benzinga
·
345d ago
Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5
Benzinga
·
345d ago
Diabetes Care Devices Market Size Projects USD 76.44 Billion by 2034
GlobeNewswire Inc.
·
352d ago
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
The Motley Fool
·
385d ago